Ray Tlv Group Ltd
Ray Tlv Group Ltd engages in the real estate business in Israel. The company was formerly known as Inelicanna Ltd and changed its name to Ray Tlv Group Ltd in November 2023. Ray Tlv Group Ltd is based in Bnei Brak, Israel.
Ray Tlv Group Ltd (RAYG-M) - Net Assets
Latest net assets as of : ILA- ILA
Based on the latest financial reports, Ray Tlv Group Ltd (RAYG-M) has net assets worth ILA- ILA as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (ILA-) and total liabilities (ILA-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ILA- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Ray Tlv Group Ltd - Net Assets Trend (None–None)
This chart illustrates how Ray Tlv Group Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Ray Tlv Group Ltd (None–None)
The table below shows the annual net assets of Ray Tlv Group Ltd from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to Ray Tlv Group Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
Ray Tlv Group Ltd Competitors by Market Cap
The table below lists competitors of Ray Tlv Group Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Las Condes
SN:LASCONDES
|
$126.42K |
|
Formuepleje EM Virksomhedsobligationer
CO:FPIEVO
|
$126.47K |
|
Danske Invest - Globale Mellemlange Indeksobligationer KL
CO:DKIGMI
|
$126.48K |
|
Model Solution Co. Ltd.
KO:417970
|
$126.49K |
|
Enter Air SA
STU:10N
|
$126.29K |
|
Formuepleje Obligationer
CO:FPIOBL
|
$126.21K |
|
Multi Manager Invest - Nye Obligationsmarkeder
CO:MMINO
|
$126.19K |
|
CHUBU EL
BE:0C2
|
$126.17K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Ray Tlv Group Ltd's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares Ray Tlv Group Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently Ray Tlv Group Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares Ray Tlv Group Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $16,087,311
- Average return on equity (ROE) among peers: -45.08%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Ray Tlv Group Ltd (RAYG-M) | ILA- | N/A | N/A | $126.38K |
| Canzon Israel Ltd (CNZN) | $7.46 Million | -32.77% | 0.24x | $18.43K |
| Intercure (INCR) | $24.07 Million | 1.10% | 0.15x | $367.38K |
| Nextage Therapeutics Ltd (NXTG) | $-1.65 Million | 0.00% | 0.00x | $70.01K |
| Rekah Pharmaceutical Industry Ltd (REKA) | $48.86 Million | 18.05% | 3.13x | $385.28K |
| Seach Medical Group Ltd (SEMG) | $-362.00K | 0.00% | 0.00x | $278.78K |
| Together Startup Network Ltd (TGTR) | $1.19 Million | -32.91% | 2.27x | $124.45K |
| Tikun Olam Cannbit Pharmaceuticals Ltd (TKUN) | $33.04 Million | -269.00% | 1.32x | $75.63K |